Φορτώνει......
Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine.
The Ebola virus is transmitted by direct contact with bodily fluids of infected individuals, eliciting death rates as high as 90% among infected humans. Currently, replication defective adenovirus-based Ebola vaccine is being studied in a phase I clinical trial. Another Ebola vaccine, based on an at...
Αποθηκεύτηκε σε:
Κύριοι συγγραφείς: | , , , , , , |
---|---|
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
Public Library of Science (PLoS)
2009-01-01
|
Σειρά: | PLoS ONE |
Διαθέσιμο Online: | http://europepmc.org/articles/PMC2669164?pdf=render |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|